| Literature DB >> 25030422 |
P Anoop Chandran1, Andreas Keller2, Lasse Weinmann3, Ahmed Adel Seida4, Matthias Braun5, Katerina Andreev6, Birgitt Fischer7, Evi Horn7, Stefanie Schwinn5, Markus Junker4, Roland Houben8, Yvonne Dombrowski4, Johannes Dietl7, Susetta Finotto6, Matthias Wölfl5, Gunter Meister9, Jörg Wischhusen10.
Abstract
Cytokine secretion and degranulation represent key components of CD8(+) T-cell cytotoxicity. While transcriptional blockade of IFN-γ and inhibition of degranulation by TGF-β are well established, we wondered whether TGF-β could also induce immune-regulatory miRNAs in human CD8(+) T cells. We used miRNA microarrays and high-throughput sequencing in combination with qRT-PCR and found that TGF-β promotes expression of the miR-23a cluster in human CD8(+) T cells. Likewise, TGF-β up-regulated expression of the cluster in CD8(+) T cells from wild-type mice, but not in cells from mice with tissue-specific expression of a dominant-negative TGF-β type II receptor. Reporter gene assays including site mutations confirmed that miR-23a specifically targets the 3'UTR of CD107a/LAMP1 mRNA, whereas the further miRNAs expressed in this cluster-namely, miR-27a and -24-target the 3'UTR of IFN-γ mRNA. Upon modulation of the miR-23a cluster by the respective miRNA antagomirs and mimics, we observed significant changes in IFN-γ expression, but only slight effects on CD107a/LAMP1 expression. Still, overexpression of the cluster attenuated the cytotoxic activity of antigen-specific CD8(+) T cells. These functional data thus reveal that the miR-23a cluster not only is induced by TGF-β, but also exerts a suppressive effect on CD8(+) T-cell effector functions, even in the absence of TGF-β signaling.Entities:
Keywords: antigen-specific T cells; miRNA induction; tolerance; tumor targets
Mesh:
Substances:
Year: 2014 PMID: 25030422 DOI: 10.1189/jlb.3A0114-025R
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962